Essex Bio-Technology Limited (HKG:1061)
Hong Kong · Delayed Price · Currency is HKD 4.430
+0.010 (0.23%)
At close: Feb 13, 2026
Essex Bio-Technology Market Cap
Essex Bio-Technology has a market cap or net worth of 2.51 billion as of February 13, 2026. Its market cap has increased by 57.63% in one year.
Market Cap
2.51B
Enterprise Value
2.16B
Revenue
1.72B
Ranking
n/a
PE Ratio
8.04
Stock Price
4.43
Market Cap Chart
Since June 27, 2001, Essex Bio-Technology's market cap has increased from 507.69M to 2.51B, an increase of 394.76%. That is a compound annual growth rate of 6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.51B | 17.51% |
| Dec 31, 2025 | 2.14B | 28.20% |
| Dec 31, 2024 | 1.67B | 17.98% |
| Dec 29, 2023 | 1.41B | -41.13% |
| Dec 30, 2022 | 2.40B | -15.72% |
| Dec 31, 2021 | 2.85B | 15.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Shineway Pharmaceutical Group | 7.50B |
| Edding Genor Group Holdings | 5.87B |
| VISEN Pharmaceuticals | 3.50B |
| Hua Medicine (Shanghai) | 3.10B |
| Jacobson Pharma Corporation | 2.52B |
| Golden Throat Holdings Group Company | 2.35B |
| JBM (Healthcare) | 2.21B |
| Dawnrays Pharmaceutical (Holdings) | 1.77B |